Published: Jan 20, 2022, 02:17 IST | Updated: Jan 20, 2022, 02:17 IST
The Serbian tennis star Novak Djokovic who became a focus of the global vaccine debate over his failed attempt to enter Australia without being inoculated, holds a majority stake in a Danish biotech firm aiming to develop a treatment to counter Covid-19.